KI-basierten Wirkstoffkandidaten YA-101Beyond's analysis on KI-basierten Wirkstoffkandidaten YA-1012026-07-30 — Dasher Neuroscience finishes patient enrollment for global Phase 2 trial of AI‑designed YA‑101 targeting multiple system atrophyBrowse the full archive →